Spots Global Cancer Trial Database for A Pilot Study of Trans Arterial Chemoembolization (TACE), Followed by Stereotactic Radiation Therapy (SBRT) for Patients With Hepatocellular Carcinoma

The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.

Trial Identification

Brief Title: A Pilot Study of Trans Arterial Chemoembolization (TACE), Followed by Stereotactic Radiation Therapy (SBRT) for Patients With Hepatocellular Carcinoma

Official Title: RAD 0902: A Pilot Study of Trans Arterial Chemoembolization (TACE), Followed by Stereotactic Radiation Therapy (SBRT) for Patients With Hepatocellular Carcinoma

Study ID: NCT01247298

Conditions

Hepatocellular Carcinoma (HCC)

Interventions

Stereotactic Body Radiation Therapy (SBRT)

Study Description

Brief Summary: This investigational study will evaluate if using a combination of TACE along with high dose SBRT would show improvement in local control in patients with Hepatocellular Carcinoma.

Detailed Description: Primary objectives of this research 1. Evaluate the safety of a combination of TACE and high dose SBRT 2. Measure time to progression (TTP) and local recurrence rate of HCC treated with a combination of TACE \& SBRT. Secondary objectives of this research 1. Assess failure patterns and survival of patients treated with TACE \& SBRT. 2. Analyze dose volume characteristics that influence Radiation Induced Liver Disease (RILD) among patients treated with a combination of TACE and SBRT.